Future outlook for treatment of chronic hepatitis C: IFN + ribavirin combination therapy

Iino S

首页> 外文期刊>臨床病理 >Future outlook for treatment of chronic hepatitis C: IFN + ribavirin combination therapy

【24h】

Future outlook for treatment of chronic hepatitis C: IFN + ribavirin combination therapy

机译：慢性丙型肝炎的治疗前景：IFN +利巴韦林联合治疗

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Japan has over 2 million patients infected with HCV and is currently facing a crisis of rapid increase in the number of patients with HCV-related liver cirrhosis and hepatocellular carcinoma. To overcome this situation, reliance is placed mainly on IFN therapy with the addition of various therapies to treat symptoms. The knowledge gained to date with IFN monotherapy and the expectations for efficacy to be achieved with IFN + ribavirin combination therapy have been presented.

机译：日本有超过200万人感染了HCV，目前正面临着与HCV相关的肝硬化和肝细胞癌患者数量迅速增加的危机。为了克服这种情况，主要依靠干扰素治疗以及各种治疗症状的疗法。迄今为止，已经介绍了通过IFN单药治疗获得的知识以及使用IFN +利巴韦林联合治疗可获得的疗效预期。

著录项

来源
《臨床病理》 |2001年第8期|共8页
作者
Iino S;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 jpn
中图分类病理学;
关键词
Antiviral Agents; Hepatitis C; Chronic; Interferons; Ribavirin; 抗病毒药; 肝炎; 丙型; 慢性; 干扰素类; 利巴韦林;

机译：Antiviral Agents;Hepatitis C;Chronic;Interferons;Ribavirin;抗病毒药;肝炎;丙型;慢性;干扰素类;利巴韦林;

相似文献

外文文献
中文文献
专利

1. Future outlook for treatment of chronic hepatitis C: IFN + ribavirin combination therapy [J] . Iino S 臨床病理 . 2001,第8期

机译：慢性丙型肝炎的治疗前景：IFN +利巴韦林联合治疗
2. Peginterferon (PEG-IFN) plus ribavirin combination therapy, but neither interferon nor PGE-IFN alone, induced type 1 diabetes in a patient with chronic hepatitis C. [J] . Ogihara T, Katagiri H, Yamada Internal medicine. . 2009,第16期

机译：聚乙二醇干扰素（PEG-IFN）联合利巴韦林联合治疗，但单独的干扰素和PGE-IFN均未诱发慢性丙型肝炎患者的1型糖尿病。
3. Associations between human TRIM22 gene expression and the response to combination therapy with Peg-IFNα-2a and ribavirin in Iranian patients with chronic hepatitis C [J] . SadeghiF., Bokharaei-SalimF., Salehi-VaziriM., Journal of Medical Virology . 2014,第9期

机译：伊朗慢性丙型肝炎患者人TRIM22基因表达与Peg-IFNα-2a和利巴韦林联合治疗反应的相关性
4. Studies of Therapy with Thymosin α 1 in Combination with Pegylated Interferon α2a and Ribavirin in Nonresponder Patients with Chronic Hepatitis C [C] . ROBERTO CAMERINI, ALESSIA CIANCIO, ALFONSO DE ROSA, International Symposiumn on Thymosins in Health and Disease; 20070321-24; Washington,DC(US) . 2007

机译：胸腺素α1联合聚乙二醇化干扰素α2a和利巴韦林治疗慢性丙型肝炎无反应者的研究
5. The meaning of adherence among veterans receiving pegylated interferon and ribavirin antiviral treatment for chronic hepatitis C. [D] . Phillips, Frances Hinshaw. 2011

机译：接受聚乙二醇干扰素和利巴韦林抗病毒治疗的慢性丙型肝炎退伍军人依从性的含义。
6. Early dynamics of viremia in patients with genotype 1b chronic hepatitis C: Peg-IFNα2a shows earlier viral decline than peg-IFNα2b in combination therapy with ribavirin [O] . Tatsuya Fujino, Makoto Nakamuta, Yoko Aoyagi, 2011

机译：基因型1b慢性丙型肝炎患者病毒血症的早期动态：与利巴韦林联合治疗时peg-IFNα2a的病毒下降比peg-IFNα2b的病毒下降更早
7. 3. New Development in Anti-viral Therapy of Type C Chronic Hepatitis - Peg-IFN/ribavirin Combination Therapy and a New Anti-viral Treatment [O] . Naoki Hiramatsu 2008

机译：3. C型慢性肝炎抗病毒治疗的新发展 - PEG-IFN /利巴韦林组合治疗及新的抗病毒治疗

Future outlook for treatment of chronic hepatitis C: IFN + ribavirin combination therapy

摘要

著录项

相似文献

相关主题

期刊订阅